We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PPH market cap is 470.97M. The company's latest EPS is USD 17.1336 and P/E is 5.10.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.3M | 4.21M | 5.62M | 8.92M | 10.39M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -25.57M | 28.27M | 41.02M | -57.82M | 92.32M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 150.04M | 237.56M | 340M | 580.24M | 448.42M |
| Total Liabilities | 8.38M | 2.41M | 21.06M | 56.5M | 18.37M |
| Total Equity | 141.66M | 235.15M | 318.94M | 523.74M | 430.05M |
| Market Cap | 470.97M |
| Price to Earnings Ratio | 5.10 |
| Price to Sales Ratio | 45.31 |
| Price to Cash Ratio | 1.76k |
| Price to Book Ratio | 1.09 |
| Dividend Yield | - |
| Shares Outstanding | 5.39M |
| Average Volume (1 week) | 401.76k |
| Average Volume (1 Month) | 168.83k |
| 52 Week Change | 10.52% |
| 52 Week High | 91.16 |
| 52 Week Low | 74.05 |
| Spread (Intraday) | 2.91 (3.28%) |
| Company Name | VanEck Pharmaceuticals ETF |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vaneck.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
